Case Report: Pembrolizumab in a patient with preexisting paraneoplastic dermatomyositis and sarcomatoid urothelial carcinoma. Searching for balance

Case Report: Pembrolizumab in a patient with preexisting paraneoplastic dermatomyositis and sarcomatoid urothelial carcinoma. Searching for balance

Dermatomyositis (DM) is an uncommon systemic autoimmune disorder classified as one of the idiopathic inflammatory myopathies (IIM). DM could also represent a manifestation of an underlying neoplasm with a relative risk of cancer globally ranging from 3% to 8%. Owing to the strong connection between...

Full description

Saved in:
Bibliographic Details
Main Authors: Mariangela Torniai, Giuseppe Pio Martino, Calogero Gucciardino, Stefano Angelici, Renato Bisonni
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-03-01
Series:Frontiers in Immunology
Subjects:
immunotherapy
paraneoplastic syndrome
autoimmune disease
dermatomyositis
urothelial carcinoma
pembrolizumab
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1558964/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items